ciprofloxacin has been researched along with Drug-Induced Stevens Johnson Syndrome in 22 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
" Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 5.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
"This survey considers 8 cases of toxic epidermal necrolysis diagnosed and treated in our clinic from 2003 to 2007." | 1.36 | Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis. ( Hanken, I; Sander, CA; Schimmer, M, 2010) |
" Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 1.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
"Toxic epidermal necrolysis (TEN), or Lyell's syndrome, is a fulminant bullous dermatitis." | 1.32 | Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus. ( Jongen-Lavrencic, M; Schneeberger, PM; van der Hoeven, JG, 2003) |
"Skin biopsy confirmed toxic epidermal necrolysis." | 1.32 | Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report. ( Jones, H; Mandal, B; Singh, S; Steward, M, 2004) |
"Toxic epidermal necrolysis (TEN) or Lyell's syndrome is a rare fulminating skin disease notorious for its rapidly progressive course and high mortality rate." | 1.28 | Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN). ( Alexopoulos, E; Chrisomalis, F; Karpouzas, J; Koukoudis, P; Papadimitriou, M; Papadopoulou, D; Sakellariou, G; Skenteris, N; Tsakaris, D, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (40.91) | 18.2507 |
2000's | 9 (40.91) | 29.6817 |
2010's | 3 (13.64) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Mortazavi, H | 1 |
Rostami, A | 1 |
Firooz, A | 1 |
Esmaili, N | 1 |
Ghiasi, M | 1 |
Lajevardi, V | 1 |
Amirzargar, AA | 1 |
Sheykhi, I | 1 |
Khamesipour, A | 1 |
Akhdar, M | 1 |
Vural, S | 1 |
Arakawa, A | 1 |
Arakawa, Y | 1 |
Prinz, JC | 1 |
Moghaddam, S | 1 |
Connolly, D | 1 |
Okan, G | 1 |
Yaylaci, S | 1 |
Peker, O | 1 |
Kaymakoglu, S | 1 |
Saruc, M | 1 |
Hanken, I | 1 |
Schimmer, M | 1 |
Sander, CA | 1 |
Upadya, GM | 1 |
Ruxana, K | 1 |
Cholongitas, E | 1 |
Georgousaki, C | 1 |
Spyrou, S | 1 |
Katsogridakis, K | 1 |
Dasenaki, M | 1 |
Hällgren, J | 1 |
Tengvall-Linder, M | 1 |
Persson, M | 1 |
Wahlgren, CF | 1 |
Jongen-Lavrencic, M | 1 |
Schneeberger, PM | 1 |
van der Hoeven, JG | 1 |
Mandal, B | 1 |
Steward, M | 1 |
Singh, S | 1 |
Jones, H | 1 |
Famularo, G | 1 |
Di Dona, B | 1 |
Canzona, F | 1 |
Girardelli, CR | 1 |
Cruciani, G | 1 |
Bhatia, RS | 1 |
Gohel, DR | 1 |
Oza, JJ | 1 |
Kamili, MA | 1 |
Ali, G | 1 |
Rashid, S | 1 |
Mansoor, A | 1 |
Allaqaband, GQ | 1 |
Win, A | 1 |
Evers, ML | 1 |
Chmel, H | 1 |
Moshfeghi, M | 1 |
Mandler, HD | 1 |
Yerasi, AB | 1 |
Oertel, MD | 1 |
Livasy, CA | 1 |
Kaplan, AM | 1 |
Vélez, A | 1 |
Moreno, JC | 1 |
Kundu, AK | 1 |
Tham, TC | 1 |
Allen, G | 1 |
Hayes, D | 1 |
McGrady, B | 1 |
Riddell, JG | 1 |
Sakellariou, G | 1 |
Koukoudis, P | 1 |
Karpouzas, J | 1 |
Alexopoulos, E | 1 |
Papadopoulou, D | 1 |
Chrisomalis, F | 1 |
Skenteris, N | 1 |
Tsakaris, D | 1 |
Papadimitriou, M | 1 |
2 reviews available for ciprofloxacin and Drug-Induced Stevens Johnson Syndrome
Article | Year |
---|---|
Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Ciprofloxacin; Female; Humans | 2003 |
Ciprofloxacin-induced toxic epidermal necrolysis: a case report.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Leg Ulcer; Male; M | 1997 |
20 other studies available for ciprofloxacin and Drug-Induced Stevens Johnson Syndrome
Article | Year |
---|---|
Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Case-Control Studies; Ciprofloxacin; F | 2022 |
The therapeutic potential of TNF-α antagonists in toxic epidermal necrosis: insights from two cases and adverse event reports.
Topics: Adalimumab; Anti-Bacterial Agents; Ciprofloxacin; Dermatologic Agents; Etanercept; Female; Humans; M | 2018 |
Photo-induced Stevens-Johnson syndrome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dermatitis, Phototoxic; Disease Progression; Female; Humans; S | 2014 |
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
Topics: Adult; Bile Duct Diseases; Ciprofloxacin; Deglutition Disorders; Dysuria; Female; Humans; Immunosupp | 2008 |
Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antico | 2010 |
Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
Topics: Administration, Oral; Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Ciproflo | 2009 |
Stevens-Johnson syndrome related to ciprofloxacin, possibly enhanced by overadministration of levothyroxine.
Topics: Aged; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactio | 2009 |
Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Topics: Adult; Ciprofloxacin; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; | 2003 |
Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Steven | 2004 |
Etanercept for toxic epidermal necrolysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Etanercept; Humans; Immunoglobulin G; Immunologic Factors; Mal | 2007 |
Steven Johnson syndrome following a single dose of ciprofloxacin.
Topics: Administration, Oral; Adult; Ciprofloxacin; Drug Eruptions; Humans; Male; Stevens-Johnson Syndrome | 1994 |
Steven-Johnson's syndrome following single dose of ciprofloxacin.
Topics: Ciprofloxacin; Humans; Stevens-Johnson Syndrome | 1994 |
Ciprofloxacin induced Stevens-Johnson syndrome.
Topics: Ciprofloxacin; Female; Humans; Stevens-Johnson Syndrome | 1994 |
Stevens-Johnson syndrome presumably induced by ciprofloxacin.
Topics: Adult; Ciprofloxacin; Humans; Male; Penicillin G; Stevens-Johnson Syndrome; Streptococcal Infections | 1994 |
Ciprofloxacin-induced toxic epidermal necrolysis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Female; Hospitals, University; Humans; Lupus Erythematos | 1993 |
Ciprofloxacin-induced toxic epidermal necrolysis.
Topics: Anti-Infective Agents; Ciprofloxacin; Fatal Outcome; Humans; Male; Stevens-Johnson Syndrome | 1996 |
Second case of ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Female; Fluid Therapy; Histamine H2 Antagonists; Humans | 2000 |
Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult.
Topics: Adolescent; Anemia, Hemolytic; Ciprofloxacin; Drug Eruptions; Glucosephosphate Dehydrogenase Deficie | 2000 |
Possible association between toxic epidermal necrolysis and ciprofloxacin.
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Humans; Male; Product Surveillance, Postmarketing; S | 1991 |
Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN).
Topics: Aged; Allopurinol; Amoxicillin; Carbamazepine; Child; Ciprofloxacin; Humans; Male; Mefenamic Acid; M | 1991 |